Creatinine–Cystatin C eGFR Discordance Identifies Long-Term Cardiorenal Risk in Acute Coronary Syndrome: A Cohort Study

BACKGROUND: Discordance between creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR) is common and has been associated with adverse outcomes in population-based cohorts. However, its relevance in patients with acute coronary syndrome (ACS) remains uncertain. METHODS: We conducted a retrospective cohort study including 808 patients with ACS admitted to the Cardiac Intensive Care Unit of Marqués de Valdecilla University Hospital (Santander, Spain) between 1 January, 2012 and 31 December, 2015, for whom measurements of creatinine and cystatin C at admission were available. Discordance between creatinine- and cystatin C-based eGFR was assessed using continuous indices (eGFR difference and ratio) and categorical definitions based on a threshold of 15 mL/min/1.73m². Associations with all-cause mortality, major adverse cardiovascular events (MACE), and kidney function decline were evaluated using Cox regression models adjusted for cardiovascular risk factors and creatinine-cystatin C eGFR. RESULTS: Creatinine-cystatin C eGFR discordance was present in 44.2% of patients. Over a median follow-up of 8.4 years, lower cystatin C-based relative to creatinine-based eGFR was associated with higher risks of all-cause mortality, MACE, and kidney function decline. These associations persisted among patients with preserved creatinine-based kidney function. In adjusted models, each 10 mL/min/1.73 m² increase in eGFR difference, indicating higher eGFRcys relative to eGFRcr, was associated with lower risks of mortality (Hazard Ratio [HR] 0.88, 95% Confidence Interval [CI] 0.80-0.96) and kidney function decline (HR 0.80, 95% CI 0.71-0.91), with a similar trend for MACE (HR 0.91, 95% CI 0.83-1.00). CONCLUSIONS: In patients hospitalised with ACS, eGFR discordance reflecting lower cystatin C-based eGFR than creatinine-based eGFR is associated with adverse long-term cardiorenal outcomes, even among patients with preserved creatinine-based kidney function.

Authors

Institutions

Publication Details

Journal
Journal of Nephrology
Published
2026-11-12
DOI
https://doi.org/10.1093/joneph/aajag276
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Creatinine–Cystatin C eGFR Discordance Identifies Long-Term Cardiorenal Risk in Acute Coronary Syndrome: A Cohort Study

Gema Fernández Fresnedo, Juan Carlos Ruiz, Cristina Baldeón Conde, José Luís Hernández et al.
Journal of Nephrology
Chronic Kidney Disease and Diabetes
article

Creatinine–Cystatin C eGFR Discordance Identifies Long-Term Cardiorenal Risk in Acute Coronary Syndrome: A Cohort Study

Gema Fernández Fresnedo, Juan Carlos Ruiz, Cristina Baldeón Conde, José Luís Hernández, Cristina García-Majado, José Enrique Pasache, Emilio Rodrigo Calabia
article en

Abstract

BACKGROUND: Discordance between creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR) is common and has been associated with adverse outcomes in population-based cohorts. However, its relevance in patients with acute coronary syndrome (ACS) remains uncertain. METHODS: We conducted a retrospective cohort study including 808 patients with ACS admitted to the Cardiac Intensive Care Unit of Marqués de Valdecilla University Hospital (Santander, Spain) between 1 January, 2012 and 31 December, 2015, for whom measurements of creatinine and cystatin C at admission were available. Discordance between creatinine- and cystatin C-based eGFR was assessed using continuous indices (eGFR difference and ratio) and categorical definitions based on a threshold of 15 mL/min/1.73m². Associations with all-cause mortality, major adverse cardiovascular events (MACE), and kidney function decline were evaluated using Cox regression models adjusted for cardiovascular risk factors and creatinine-cystatin C eGFR. RESULTS: Creatinine-cystatin C eGFR discordance was present in 44.2% of patients. Over a median follow-up of 8.4 years, lower cystatin C-based relative to creatinine-based eGFR was associated with higher risks of all-cause mortality, MACE, and kidney function decline. These associations persisted among patients with preserved creatinine-based kidney function. In adjusted models, each 10 mL/min/1.73 m² increase in eGFR difference, indicating higher eGFRcys relative to eGFRcr, was associated with lower risks of mortality (Hazard Ratio [HR] 0.88, 95% Confidence Interval [CI] 0.80-0.96) and kidney function decline (HR 0.80, 95% CI 0.71-0.91), with a similar trend for MACE (HR 0.91, 95% CI 0.83-1.00). CONCLUSIONS: In patients hospitalised with ACS, eGFR discordance reflecting lower cystatin C-based eGFR than creatinine-based eGFR is associated with adverse long-term cardiorenal outcomes, even among patients with preserved creatinine-based kidney function.

Journal of Nephrology
Universidad de Cantabria (ES), Marqués de Valdecilla University Hospital (ES), Instituto de Investigación Marqués de Valdecilla (ES)
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon